Clinical Trial Analysis of Different Stages of HBV Patients Treated with Human CIK Cells

Clinical Trial Analysis of Different Stages of HBV Patients Treated with Human CIK Cells

Cellular immunotherapy has become a potential therapeutic method for different diseases. Herein, we reported clinical trial results of Cytokine-induced killer (CIK) cells used for patients with hepatitis B, cirrhosis and liver cancers from 2000 to 2015. Results showed CIK cell therapeutic effects we...

Full description

Bibliographic Details
Main Authors: Fangfang Xia, Ruihua Song, Jingjing Zhang, Yang Zhu, Yao Yang, Ling He, Yun Cao, Chenlu Li, Zheng Wang, Shangli Cheng, Jian Ni, Lijun Ma, Ding Li, Daxiang Cui
Format: Article
Language:English
Published: Tsinghua University Press 2016-09-01
Series:Nano Biomedicine and Engineering
Subjects:
hepatitis b virus
cirrhosis
hepatocellular carcinoma
cytokine-induced killer cells
cell therapy
cytokine factors
Online Access:https://www.sciopen.com/article/10.5101/nbe.v8i3.p203-211

Internet

https://www.sciopen.com/article/10.5101/nbe.v8i3.p203-211

Similar Items